These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1095 related articles for article (PubMed ID: 15157098)
1. Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin. Gupta K; Bishop J; Peck A; Brown J; Wilson L; Panda D Biochemistry; 2004 Jun; 43(21):6645-55. PubMed ID: 15157098 [TBL] [Abstract][Full Text] [Related]
2. Kinetic stabilization of microtubule dynamic instability by benomyl increases the nuclear transport of p53. Rathinasamy K; Panda D Biochem Pharmacol; 2008 Dec; 76(12):1669-80. PubMed ID: 18823952 [TBL] [Abstract][Full Text] [Related]
3. Suppression of microtubule dynamics by binding of cemadotin to tubulin: possible mechanism for its antitumor action. Jordan MA; Walker D; de Arruda M; Barlozzari T; Panda D Biochemistry; 1998 Dec; 37(50):17571-8. PubMed ID: 9860873 [TBL] [Abstract][Full Text] [Related]
4. Rotenone inhibits mammalian cell proliferation by inhibiting microtubule assembly through tubulin binding. Srivastava P; Panda D FEBS J; 2007 Sep; 274(18):4788-801. PubMed ID: 17697112 [TBL] [Abstract][Full Text] [Related]
7. 3-(Iodoacetamido)-benzoylurea: a novel cancericidal tubulin ligand that inhibits microtubule polymerization, phosphorylates bcl-2, and induces apoptosis in tumor cells. Jiang JD; Davis AS; Middleton K; Ling YH; Perez-Soler R; Holland JF; Bekesi JG Cancer Res; 1998 Dec; 58(23):5389-95. PubMed ID: 9850070 [TBL] [Abstract][Full Text] [Related]
8. A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors. Tahir SK; Han EK; Credo B; Jae HS; Pietenpol JA; Scatena CD; Wu-Wong JR; Frost D; Sham H; Rosenberg SH; Ng SC Cancer Res; 2001 Jul; 61(14):5480-5. PubMed ID: 11454695 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of alpha-hydroxymethylated conjugated nitroalkenes for their anticancer activity: inhibition of cell proliferation by targeting microtubules. Mohan R; Rastogi N; Namboothiri IN; Mobin SM; Panda D Bioorg Med Chem; 2006 Dec; 14(23):8073-85. PubMed ID: 16891118 [TBL] [Abstract][Full Text] [Related]
10. Spongistatin 1, a highly cytotoxic, sponge-derived, marine natural product that inhibits mitosis, microtubule assembly, and the binding of vinblastine to tubulin. Bai R; Cichacz ZA; Herald CL; Pettit GR; Hamel E Mol Pharmacol; 1993 Oct; 44(4):757-66. PubMed ID: 8232226 [TBL] [Abstract][Full Text] [Related]
11. Microtubule assembly dynamics: an attractive target for anticancer drugs. Singh P; Rathinasamy K; Mohan R; Panda D IUBMB Life; 2008 Jun; 60(6):368-75. PubMed ID: 18384115 [TBL] [Abstract][Full Text] [Related]
12. Kinetic stabilization of microtubule dynamics by estramustine is associated with tubulin acetylation, spindle abnormalities, and mitotic arrest. Mohan R; Panda D Cancer Res; 2008 Aug; 68(15):6181-9. PubMed ID: 18676841 [TBL] [Abstract][Full Text] [Related]
13. Vitamin K3 disrupts the microtubule networks by binding to tubulin: a novel mechanism of its antiproliferative activity. Acharya BR; Choudhury D; Das A; Chakrabarti G Biochemistry; 2009 Jul; 48(29):6963-74. PubMed ID: 19527023 [TBL] [Abstract][Full Text] [Related]
14. Antimitotic sulfonamides inhibit microtubule assembly dynamics and cancer cell proliferation. Mohan R; Banerjee M; Ray A; Manna T; Wilson L; Owa T; Bhattacharyya B; Panda D Biochemistry; 2006 May; 45(17):5440-9. PubMed ID: 16634625 [TBL] [Abstract][Full Text] [Related]
15. Mechanism of action of E7010, an orally active sulfonamide antitumor agent: inhibition of mitosis by binding to the colchicine site of tubulin. Yoshimatsu K; Yamaguchi A; Yoshino H; Koyanagi N; Kitoh K Cancer Res; 1997 Aug; 57(15):3208-13. PubMed ID: 9242451 [TBL] [Abstract][Full Text] [Related]
16. Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo. Wong VK; Chiu P; Chung SS; Chow LM; Zhao YZ; Yang BB; Ko BC Clin Cancer Res; 2005 Aug; 11(16):6002-11. PubMed ID: 16115945 [TBL] [Abstract][Full Text] [Related]
17. Genistein arrests cell cycle progression of A549 cells at the G(2)/M phase and depolymerizes interphase microtubules through binding to a unique site of tubulin. Mukherjee S; Acharya BR; Bhattacharyya B; Chakrabarti G Biochemistry; 2010 Mar; 49(8):1702-12. PubMed ID: 20085293 [TBL] [Abstract][Full Text] [Related]
18. LU103793 (NSC D-669356): a synthetic peptide that interacts with microtubules and inhibits mitosis. de Arruda M; Cocchiaro CA; Nelson CM; Grinnell CM; Janssen B; Haupt A; Barlozzari T Cancer Res; 1995 Jul; 55(14):3085-92. PubMed ID: 7606731 [TBL] [Abstract][Full Text] [Related]
19. Indirubin, a bis-indole alkaloid binds to tubulin and exhibits antimitotic activity against HeLa cells in synergism with vinblastine. Mohan L; Raghav D; Ashraf SM; Sebastian J; Rathinasamy K Biomed Pharmacother; 2018 Sep; 105():506-517. PubMed ID: 29883946 [TBL] [Abstract][Full Text] [Related]
20. Salvinal, a novel microtubule inhibitor isolated from Salvia miltiorrhizae Bunge (Danshen), with antimitotic activity in multidrug-sensitive and -resistant human tumor cells. Chang JY; Chang CY; Kuo CC; Chen LT; Wein YS; Kuo YH Mol Pharmacol; 2004 Jan; 65(1):77-84. PubMed ID: 14722239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]